Copyright Reports & Markets. All rights reserved.

Global and United States Neuronal Markers Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Neuronal Markers Product Introduction
    • 1.2 Global Neuronal Markers Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Neuronal Markers Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Neuronal Markers Sales in Volume for the Year 2017-2028
    • 1.3 United States Neuronal Markers Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Neuronal Markers Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Neuronal Markers Sales in Volume for the Year 2017-2028
    • 1.4 Neuronal Markers Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Neuronal Markers in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Neuronal Markers Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Neuronal Markers Market Dynamics
      • 1.5.1 Neuronal Markers Industry Trends
      • 1.5.2 Neuronal Markers Market Drivers
      • 1.5.3 Neuronal Markers Market Challenges
      • 1.5.4 Neuronal Markers Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Neuronal Markers Market Segment by Type
      • 2.1.1 Imaging Biomarkers
      • 2.1.2 Metabolomics Biomarkers
      • 2.1.3 Proteomic Biomarkers
      • 2.1.4 Genomics Biomarkers
    • 2.2 Global Neuronal Markers Market Size by Type
      • 2.2.1 Global Neuronal Markers Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Neuronal Markers Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Neuronal Markers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Neuronal Markers Market Size by Type
      • 2.3.1 United States Neuronal Markers Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Neuronal Markers Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Neuronal Markers Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Neuronal Markers Market Segment by Application
      • 3.1.1 Spinal Muscular Atrophy (SMA)
      • 3.1.2 Multiple Sclerosis
      • 3.1.3 Depression
      • 3.1.4 Schizophrenia
      • 3.1.5 Huntington's Disease
      • 3.1.6 Parkinson's Disease
      • 3.1.7 Alzheimer's Disease
    • 3.2 Global Neuronal Markers Market Size by Application
      • 3.2.1 Global Neuronal Markers Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Neuronal Markers Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Neuronal Markers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Neuronal Markers Market Size by Application
      • 3.3.1 United States Neuronal Markers Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Neuronal Markers Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Neuronal Markers Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Neuronal Markers Competitor Landscape by Company

    • 4.1 Global Neuronal Markers Market Size by Company
      • 4.1.1 Top Global Neuronal Markers Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Neuronal Markers Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Neuronal Markers Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Neuronal Markers Price by Manufacturer (2017-2022)
    • 4.2 Global Neuronal Markers Concentration Ratio (CR)
      • 4.2.1 Neuronal Markers Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Neuronal Markers in 2021
      • 4.2.3 Global Neuronal Markers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Neuronal Markers Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Neuronal Markers Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Neuronal Markers Product Type
      • 4.3.3 Date of International Manufacturers Enter into Neuronal Markers Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Neuronal Markers Market Size by Company
      • 4.5.1 Top Neuronal Markers Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Neuronal Markers Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Neuronal Markers Sales by Players (2020, 2021 & 2022)

    5 Global Neuronal Markers Market Size by Region

    • 5.1 Global Neuronal Markers Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Neuronal Markers Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Neuronal Markers Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Neuronal Markers Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Neuronal Markers Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Neuronal Markers Sales in Value by Region: 2017-2022
      • 5.3.2 Global Neuronal Markers Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Neuronal Markers Market Size YoY Growth 2017-2028
      • 6.1.2 North America Neuronal Markers Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Neuronal Markers Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Neuronal Markers Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Neuronal Markers Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Neuronal Markers Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Neuronal Markers Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Neuronal Markers Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Neuronal Markers Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Neuronal Markers Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Athena Diagnostics
      • 7.1.1 Athena Diagnostics Corporation Information
      • 7.1.2 Athena Diagnostics Description and Business Overview
      • 7.1.3 Athena Diagnostics Neuronal Markers Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Athena Diagnostics Neuronal Markers Products Offered
      • 7.1.5 Athena Diagnostics Recent Development
    • 7.2 Myriad RBM
      • 7.2.1 Myriad RBM Corporation Information
      • 7.2.2 Myriad RBM Description and Business Overview
      • 7.2.3 Myriad RBM Neuronal Markers Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Myriad RBM Neuronal Markers Products Offered
      • 7.2.5 Myriad RBM Recent Development
    • 7.3 AbaStar MDx
      • 7.3.1 AbaStar MDx Corporation Information
      • 7.3.2 AbaStar MDx Description and Business Overview
      • 7.3.3 AbaStar MDx Neuronal Markers Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 AbaStar MDx Neuronal Markers Products Offered
      • 7.3.5 AbaStar MDx Recent Development
    • 7.4 QIAGEN
      • 7.4.1 QIAGEN Corporation Information
      • 7.4.2 QIAGEN Description and Business Overview
      • 7.4.3 QIAGEN Neuronal Markers Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 QIAGEN Neuronal Markers Products Offered
      • 7.4.5 QIAGEN Recent Development
    • 7.5 Thermo Fisher Scientific
      • 7.5.1 Thermo Fisher Scientific Corporation Information
      • 7.5.2 Thermo Fisher Scientific Description and Business Overview
      • 7.5.3 Thermo Fisher Scientific Neuronal Markers Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Thermo Fisher Scientific Neuronal Markers Products Offered
      • 7.5.5 Thermo Fisher Scientific Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Neuronal Markers Industry Chain Analysis
    • 8.2 Neuronal Markers Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Neuronal Markers Distributors
    • 8.3 Neuronal Markers Production Mode & Process
    • 8.4 Neuronal Markers Sales and Marketing
      • 8.4.1 Neuronal Markers Sales Channels
      • 8.4.2 Neuronal Markers Distributors
    • 8.5 Neuronal Markers Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
      Market Analysis and Insights: Global and United States Neuronal Markers Market
      This report focuses on global and United States Neuronal Markers market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Neuronal Markers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Imaging Biomarkers accounting for % of the Neuronal Markers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Spinal Muscular Atrophy (SMA) was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Neuronal Markers market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Neuronal Markers Scope and Market Size
      Neuronal Markers market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Neuronal Markers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Neuronal Markers market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Neuronal Markers market is segmented into
      Imaging Biomarkers
      Metabolomics Biomarkers
      Proteomic Biomarkers
      Genomics Biomarkers
      Segment by Application, the Neuronal Markers market is segmented into
      Spinal Muscular Atrophy (SMA)
      Multiple Sclerosis
      Depression
      Schizophrenia
      Huntington's Disease
      Parkinson's Disease
      Alzheimer's Disease
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Neuronal Markers Market Share Analysis
      Neuronal Markers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuronal Markers business, the date to enter into the Neuronal Markers market, Neuronal Markers product introduction, recent developments, etc.
      The major vendors covered:
      Athena Diagnostics
      Myriad RBM
      AbaStar MDx
      QIAGEN
      Thermo Fisher Scientific
      Buy now